Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Cobb

Showing results (161-170 of 300) with videos related to

Pageof 30
Sort By:
Journal of Proteome Research|November 9, 2021
Cholesterol Regulates the Tumor Adaptive Resistance to MAPK Pathway InhibitionXu-Dong Wang, Chiho Kim, Yajie Zhang, et al.
Biochemistry|May 23, 2000
Catalytic reaction pathway for the mitogen-activated protein kinase ERK2C N Prowse, J C Hagopian, M H Cobb, et al.
Developmental Biology|August 1, 1993
MAP kinase becomes stably activated at metaphase and is associated with microtubule-organizing centers during meiotic maturation of mouse oocytesM H Verlhac, H de Pennart, B Maro, et al.
The Journal of Biological Chemistry|September 13, 2007
WNK1 is a novel regulator of Munc18c-syntaxin 4 complex formation in soluble NSF attachment protein receptor (SNARE)-mediated vesicle exocytosisEunjin Oh, Charles J Heise, Jessie M English, et al.
Archives of Biochemistry and Biophysics|April 22, 2006
The MAP kinase ERK5 binds to and phosphorylates p90 RSKAarati Ranganathan, Gray W Pearson, Carol A Chrestensen, et al.
Science Signaling|December 15, 2016
Chemoattractant concentration-dependent tuning of ERK signaling dynamics in migrating neutrophilsElizabeth R Zhang, Shanshan Liu, Lani F Wu, et al.
Molecular and Cellular Endocrinology|July 1, 1982
Mineralocorticoid-induced membrane proteins in MDCK cellsM H Cobb, C P Yang, D M Jefferson, et al.
Biochemistry|July 16, 2013
Off-target effects of MEK inhibitorsEric M Wauson, Marcy L Guerra, Barbara Barylko, et al.
Molecular Cell|June 28, 2002
Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3bChung I Chang, Bing-e Xu, Radha Akella, et al.
Current Biology : CB|November 4, 1998
A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformationM J Robinson, S A Stippec, E Goldsmith, et al.
Pageof 30

Showing results (161-170 of 300) with videos related to

Sort By:
Pageof 30
Journal of Proteome Research|November 9, 2021
Cholesterol Regulates the Tumor Adaptive Resistance to MAPK Pathway InhibitionXu-Dong Wang, Chiho Kim, Yajie Zhang, et al.
Biochemistry|May 23, 2000
Catalytic reaction pathway for the mitogen-activated protein kinase ERK2C N Prowse, J C Hagopian, M H Cobb, et al.
Developmental Biology|August 1, 1993
MAP kinase becomes stably activated at metaphase and is associated with microtubule-organizing centers during meiotic maturation of mouse oocytesM H Verlhac, H de Pennart, B Maro, et al.
The Journal of Biological Chemistry|September 13, 2007
WNK1 is a novel regulator of Munc18c-syntaxin 4 complex formation in soluble NSF attachment protein receptor (SNARE)-mediated vesicle exocytosisEunjin Oh, Charles J Heise, Jessie M English, et al.
Archives of Biochemistry and Biophysics|April 22, 2006
The MAP kinase ERK5 binds to and phosphorylates p90 RSKAarati Ranganathan, Gray W Pearson, Carol A Chrestensen, et al.
Science Signaling|December 15, 2016
Chemoattractant concentration-dependent tuning of ERK signaling dynamics in migrating neutrophilsElizabeth R Zhang, Shanshan Liu, Lani F Wu, et al.
Molecular and Cellular Endocrinology|July 1, 1982
Mineralocorticoid-induced membrane proteins in MDCK cellsM H Cobb, C P Yang, D M Jefferson, et al.
Biochemistry|July 16, 2013
Off-target effects of MEK inhibitorsEric M Wauson, Marcy L Guerra, Barbara Barylko, et al.
Molecular Cell|June 28, 2002
Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3bChung I Chang, Bing-e Xu, Radha Akella, et al.
Current Biology : CB|November 4, 1998
A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformationM J Robinson, S A Stippec, E Goldsmith, et al.
Pageof 30